|
701 |
Annual acknowledgement of manuscript reviewers
Enthalten in Harm reduction journal Bd. 12, 20.3.2015, Nr. 1, date:12.2015: 1-2
|
|
|
|
702 |
Annual acknowledgement of manuscript reviewers
Enthalten in Theoretical biology and medical modelling Bd. 12, 3.7.2015, Nr. 1, date:12.2015: 1-3
|
|
|
|
703 |
Anti-Craving Therapie als Erfolgsfaktor
Enthalten in Psychopraxis. Neuropraxis Bd. 20, 29.3.2017, Nr. 2, date:4.2017: 92-93
|
|
|
|
704 |
Anti-semitism and Xenophobia*
Enthalten in The American journal of psychoanalysis Bd. 77, 23.10.2017, Nr. 4, date:12.2017: 378-391
|
|
|
|
705 |
Anticipating the Ethical Challenges of Psychiatric Genetic Testing
Enthalten in Current psychiatry reports Bd. 19, 22.5.2017, Nr. 7, date:7.2017: 1-6
|
|
|
|
706 |
Antidepressive Psychotherapie: neuronale Konnektivität als Outcome-Prädiktor
Enthalten in Der Neurologe & Psychiater Bd. 18, 31.7.2017, Nr. 7-8, date:8.2017: 16
|
|
|
|
707 |
Antipsychotic-induced hyperprolactinemia: synthesis of world-wide guidelines and integrated recommendations for assessment, management and future research
Enthalten in Psychopharmacology Bd. 234, 9.9.2017, Nr. 22, date:11.2017: 3279-3297
|
|
|
|
708 |
Antipsychotic polypharmacy prescribing and risk of hospital readmission
Enthalten in Psychopharmacology Bd. 235, 28.10.2017, Nr. 1, date:1.2018: 281-289
|
|
|
|
709 |
Antipsychotic prescribing for vulnerable populations: a clinical audit at an acute Australian mental health unit at two-time points
Enthalten in BMC psychiatry Bd. 17, 13.4.2017, Nr. 1, date:12.2017: 1-10
|
|
|
|
710 |
Antipsychotic use is a risk factor for hyponatremia in patients with schizophrenia: a 15-year follow-up study
Enthalten in Psychopharmacology Bd. 234, 11.1.2017, Nr. 5, date:3.2017: 869-876
|
|
Administration
